GSE130953 Myeloablation followed by autologous stem cell transplantation normalizes systemic sclerosis molecular signatures

Contributors : Shervin Assassi ; Xuan Wang ; Guocai Chen ; Ellen A Goldmuntz ; Lynette Keyes-Elstein ; Jun Ying ; Paul K Wallace ; Jacob Turner ; W J Zheng ; Virginia Pascual ; John Varga ; Monique E Hinchcliff ; Chiara Bellocchi ; Peter McSweeney ; Daniel E Furst ; Rechard A Nash ; Leslie J Crofford ; Beverly Welch ; Ashely Pinckney ; Maureen D Mayes ; Keith M SullivanSeries Type : Expression profiling by arrayOrganism : Homo sapiensThis is global gene expression study of whole blood samples collected in the Cyclophosphamide Or Transplantation (SCOT) randomized controlled trial, as well as unaffected controls.Patients with diffuse cutaneous systemic sclerosis (scleroderma) received either myeloablation followed by autologous stem cell transplantation or intravenous cyclophosphamide
Source: GEO: Gene Expression Omnibus - Category: Genetics & Stem Cells Tags: Expression profiling by array Homo sapiens Source Type: research